Streptozotocin-induced liver damage in mice

Area of Science:

• Endocrinology
• Hepatology
• Toxicology

Background:

• Streptozotocin (SZ) is widely used to induce diabetes in research models.
• The timing of SZ administration may influence its toxic effects on pancreatic beta-cells and hepatocytes.
• Circadian variations in cellular sensitivity to toxins are increasingly recognized.

Purpose of the Study:

• To investigate the circadian variation in diabetes incidence and liver damage induced by Streptozotocin (SZ) in C3H-s mice.
• To assess the relationship between the timing of SZ administration and the severity of metabolic disturbances and hepatotoxicity.
• To determine if liver damage occurs independently of diabetes development following SZ injection.

Main Methods:

• C3H-s mice were injected intravenously with Streptozotocin (250 mg/kg) at 4 a.m. and 4 p.m.
• Metabolic disturbances were monitored daily via glycosuria and final serum glucose levels.
• Liver damage was evaluated using light and electron microscopy, examining cellular structures like endoplasmic reticulum and mitochondria.

Main Results:

• Both diabetes incidence and liver damage exhibited circadian variation, with significantly higher values observed in the 4 p.m. injected group.
• Hepatotoxicity, characterized by endoplasmic reticulum degranulation and mitochondrial swelling, occurred irrespective of whether the animals developed diabetes.
• Cellular damage included mitochondrial swelling, loss of cristae, and endoplasmic reticulum cisternae dilation.

Conclusions:

• Beta-cells and hepatocytes demonstrate synchronized circadian sensitivity to Streptozotocin.
• Liver damage from SZ can occur at a lower threshold than that required to induce diabetes, suggesting differential cellular sensitivity.
• The timing of SZ administration is a critical factor influencing experimental outcomes and should be considered in research and clinical settings.